Back
Cyclacel Pharmaceuticals Vs. Simulations Plus Industry Stock Comparison
Sell
23
CYCC
Cyclacel Pharmaceuticals
Last Price:
0.90
Seasonality Move:
-6.36%
Sell
29
SLP
Simulations Plus
Last Price:
30.22
Seasonality Move:
5.81%
Sell
23
Cyclacel Pharmaceuticals (CYCC)
is a Sell
Is Cyclacel Pharmaceuticals a Buy, Sell or Hold?
- The current Cyclacel Pharmaceuticals [CYCC] share price is $0.92. The Score for CYCC is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- CYCC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Simulations Plus (SLP)
is a Sell
Is Simulations Plus a Buy, Sell or Hold?
- The current Simulations Plus [SLP] share price is $30.24. The Score for SLP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- SLP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYCC Stock Price Chart
What is Cyclacel Pharmaceuticals's stock price today?
-
The Cyclacel Pharmaceuticals share price today is $0.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYCC is experiencing slight selling pressure.
SLP Stock Price Chart
What is Simulations Plus's stock price today?
-
The Simulations Plus share price today is $30.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLP is experiencing slight selling pressure.
CYCC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 30.35 | Sell |
Chaikin Money Flow: | -10057 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.98 - 1.06) | Sell |
Bollinger Bands (100): | (1.12 - 1.98) | Sell |
SLP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.31 | Sell |
Relative Strength Index (14 RSI): | 30.98 | Sell |
Chaikin Money Flow: | -3761 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.89 - 34.25) | Sell |
Bollinger Bands (100): | (34.11 - 46.87) | Sell |
CYCC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.98 | Sell |
20-day SMA: | 1.02 | Sell |
50-day SMA: | 1.22 | Sell |
200-day SMA: | 1.96 | Sell |
8-day EMA: | 0.97 | Sell |
20-day EMA: | 1.02 | Sell |
50-day EMA: | 1.2 | Sell |
200-day EMA: | 2.67 | Sell |
SLP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.1 | Sell |
20-day SMA: | 31.9 | Sell |
50-day SMA: | 35.08 | Sell |
200-day SMA: | 41.64 | Sell |
8-day EMA: | 31.12 | Sell |
20-day EMA: | 32.14 | Sell |
50-day EMA: | 34.98 | Sell |
200-day EMA: | 40.27 | Sell |
Cyclacel Pharmaceuticals Earnings Growth & CYCC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $405.03 per share, and an increase next year of $0.73 per share.
Simulations Plus Earnings Growth & SLP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.08 per share.
Cyclacel Pharmaceuticals Technical Analysis
Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Simulations Plus Technical Analysis
Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |